The FDA has issued guidelines allowing for faster development of updated coronavirus vaccines, based on previously approved shots The post FDA guidance allows fast updates of...
The U.S. Food and Drug Administration accepted for Priority Review Pfizer Inc.’s Biologics License Application for TicoVac, the company's tick-borne encephalitis vaccine for active immunization to...
FDA to allow Pfizer-BioNTech vaccine to be stored at higher temps: NYT (Reuters) – The U.S. Food & Drug Administration plans to approve Pfizer Inc and...
The U.S. Food and Drug Administration issued new guidance for vaccine makers as the regulatory agency is preparing for the possibility of needing to approve Covid-19...
Drugmakers should test any Covid-19 vaccines that have been retooled to combat new variants of the coronavirus in clinical trials designed to track the immune response...
Incyte announced that the US Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) of its ruxolitinib cream. Shares of...
Sanofi and GlaxoSmithKline are restarting clinical development of their COVID-19 vaccine, which was delayed after hitting a snag
Pharma’s pipeline continues to provide drama as investors look beyond COVID-19...
Novavax has signed a memorandum of understanding (MOU) with the vaccine alliance, Gavi, to provide 1.1 billion doses of its recombinant protein-based COVID-19 vaccine, NVX-CoV2373, for...
B. Riley analyst Mayank Mamtani has long banged the drum for Novavax (NVAX). The latest developments surrounding the company have only reaffirmed his bullish outlook for...
Novavax announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance, to provide 1.1 billion doses of the company's Covid-19 vaccine candidate NVX-CoV2373 for the COVAX...
Pfizer Inc. and BioNTech SE asked the U.S. health regulator to relax requirements for their Covid-19 vaccine to be stored at ultra-low temperatures, potentially allowing for...
Amidst the COVID-19 pandemic, West Africa is facing a new outbreak of Ebola. A global emergency stockpile of The post West Africa prepares for Ebola vaccination...
Johns Hopkins Prof Sees US Herd Immunity By April, Fauci Fearmongers 2022 For 'Return To Normality' Be afraid, be very afraid (oh, and do not push...
Two researchers have suggested that the second dose of Pfizer and BioNTech’s COVID-19 vaccine could be delayed, as The post Scientists make case for one dose...
Johnson & Johnson Jab May Require More Than 1 Dose To Be Effective
With distribution of Covid-19 vaccines being slow, public health officials and researchers are trying to develop schemes and rationales for delaying the dosing of the second...
Doctors Endorse Delay Of 2nd Pfizer Jab Even As New Research Shows Low Efficacy Against South African 'Mutant' Following a flurry of data suggesting the first...
With a third of adults saying they likely won't get the vaccine and 20% of the population under 16, the US has a herd immunity math...
COVID-19 has already proved to be a digital accelerant for the pharmaceutical industry, sparking new ideas into life The post No cooling off for pharma digital...
US CDC Weighs Extending Interval Between COVID Jab Doses In what could become another major messaging flip-flop from the CDC, after repeatedly urging all eligible Americans...
The US has a herd immunity math problem, with a COVID-19 vaccine not yet approved for children under 16 and a third of adults saying they...
Kroger Co.'s healthcare division has partnered with Gauss to provide a smartphone-enabled, at-home COVID-19 rapid antigen test kit to patients. The antigen test is currently awaiting...
Novavax and SK Group's vaccine subsidiary extended their collaboration and license agreement for the manufacturing of an additional 40 million doses of its COVID-19 vaccine for...
AstraZeneca announced yesterday that the World Health Organization (WHO) has granted an Emergency Use Listing (EUL) for its COVID-19 vaccine. The authorization permits the global use...
The U.S. Food and Drug Administration approved Pfizer Inc.'s supplemental Biologics License Application for Panzyga to treat adult patients with a rare neurological disease of the...
Sanofi’s CEO, Paul Hudson, said that the mRNA-based COVID-19 vaccine developed with Translate Bio will not be ready this year
India Today has reported that Tesla will be opening an electric vehicle (EV) manufacturing plant in Karnataka, India, according to a statement released by Chief Minister...
On Feb. 12, medical technology company Becton Dickinson & Co announced that it had received emergency use authorization (EUA) from the U.S. Food and Drug Administration...
G1 Therapeutics announced that the US Food and Drug Administration (FDA) has approved its COSELA drug as a first-of-its-kind treatment for patients with extensive-stage small cell...